During the past decade, Masih Daneshvari Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Masih Daneshvari Hospital" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials, followed by "Arda Kiani" with 1 trials sponsored, "AryoGen Pharmed Co." with 1 trials sponsored, "Cinnagen" with 1 trials sponsored and "Manuel Monreal" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Masih Daneshvari Hospital" #1 collaborator was "Masih Daneshvari Hospital" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Firuzgar hospital affiliated to Iran University of Medical Sciences" with 1 trials as a collaborator, "Hazrat Rasool Hospital" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Masih Daneshvari Hospital" are "Acute Respiratory Failure" (1 trials), "Central Sleep Apnea, Secondary" (1 trials), "Covid19" (1 trials), "Emphysema" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Masih Daneshvari Hospital" in a lesser frequency.

Most popular intervention types in "Masih Daneshvari Hospital" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetazolamide-placebo" (1 trials), "Atorvastatin 20mg" (1 trials), "Autologous MSCs transplantation" (1 trials), "Bevacizumab + FOLFIRI-3" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Masih Daneshvari Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Masih Daneshvari Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Masih Daneshvari Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Masih Daneshvari Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Masih Daneshvari Hospital has several departments that took part in Clinical trials: "Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute (NNFTRI) and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran" - 8 trials, "Faculty of Nutrition Sciences and Food Technology" - 5 trials, "Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute" - 3 trials, "School of Dentristry at Shahid Beheshti University of Medical Sciences" - 3 trials, "Baqiyatallah Research Center for Gastroenterology and Liver Diseases" - 2 trials, "National Research Institute of Tuberculosis and Lung Disease (NRITLD)" - 2 trials